Aptamer‐Engineered Natural Killer Cells for Cell‐Specific Adaptive Immunotherapy

Strategy for Generating Sequence-Defined Aptamer Reagent Sets for Detecting Protein Contaminants in Biotherapeutics

(2018) James B. McGivney et al.   ANALYTICAL CHEMISTRY

Recent Advances in Fluorescent Probes for Lipid Droplets

(2018) Tkhe Fam et al.   Materials

Oligonucleotide Aptamer-mediated Precision Therapy of Hematological Malignancies

(2018) Shuanghui Yang et al.   Molecular Therapy-Nucleic Acids

A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice

(2017) Tal Gefen et al.   MOLECULAR THERAPY

NK cell-based immunotherapy for cancer

(2017) Fang Fang et al.   SEMINARS IN IMMUNOLOGY

Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions

(2017) C A van der Weyden et al.   Blood Cancer Journal

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9

(2017) Jiangtao Ren et al.   Protein & Cell

Bioengineering Solutions for Manufacturing Challenges in CAR T Cells

(2017) Nicole J. Piscopo et al.   Biotechnology Journal

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models

(2017) Pinar Kanlikilicer et al.   Molecular Therapy-Nucleic Acids

Molecular modeling of lipid probes and their influence on the membrane

(2016) Roland Faller   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

From selection hits to clinical leads: progress in aptamer discovery

(2016) Keith E Maier et al.   Molecular Therapy-Methods & Clinical Development

Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens

(2015) Richard W. Childs et al.   NATURE REVIEWS DRUG DISCOVERY

Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine

(2015) Dongxi Xiang et al.   Theranostics

Advantages and applications of CAR-expressing natural killer cells

(2015) Wolfgang Glienke et al.   Frontiers in Pharmacology

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity

(2015) Carin I. M. Dahlberg et al.   Frontiers in Immunology

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

(2014) M. V. Maus et al.   BLOOD

Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease

(2014) James O.J. Davies et al.   CYTOTHERAPY

Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity

(2014) C. J. Braun et al.   Science Translational Medicine

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

(2014) Hongguang Sun et al.   Molecular Therapy-Nucleic Acids

Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer

(2013) Parag Parekh et al.   BIOMATERIALS

Fluorescent Probes for Lipid Rafts: From Model Membranes to Living Cells

(2013) Andrey S. Klymchenko et al.   CHEMISTRY & BIOLOGY

CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma

(2013) J Chu et al.   LEUKEMIA

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

(2013) Stephan A. Grupp et al.   NEW ENGLAND JOURNAL OF MEDICINE

DNA Aptamer-Mediated Cell Targeting

(2012) Xiangling Xiong et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Partitioning, diffusion, and ligand binding of raft lipid analogs in model and cellular plasma membranes

(2012) Erdinc Sezgin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1

(2012) Jeffrey M. Venstrom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bone marrow and the control of immunity

(2011) Ende Zhao et al.   Cellular & Molecular Immunology

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

(2010) J. A. Olson et al.   BLOOD

NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

(2010) Jeffrey E. Rubnitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

(2010) Stefan Stein et al.   NATURE MEDICINE

Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method

(2009) L Li et al.   CANCER GENE THERAPY

Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells

(2009) Laurent Boissel et al.   LEUKEMIA RESEARCH

Effects of α-tocopherol (vitamin E) on the stability and lipid dynamics of model membranes mimicking the lipid composition of plant chloroplast membranes

(2008) Dirk K. Hincha   FEBS LETTERS

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

(2008) Steven J. Howe et al.   JOURNAL OF CLINICAL INVESTIGATION